Recent advances in radiation oncology.

Radiotherapy remains an important component of the management of malignant disease. Especially when combined with cytotoxic chemotherapy, limited surgical excision, or both, irradiation has been shown to control disease in the primary site and regional nodes without the need for surgical extirpation as frequently as in past years. New developments in three-dimensional treatment planning and the precise delivery of high-dose radiation promise to increase the benefit of radiation treatment. Finally, molecular studies of the cell's response to radiation and the phenomena of DNA damage and repair are providing explanations for heretofore unexplained radiobiologic observations. Such research is laying the groundwork for targeted manipulation of the cell's response to radiation, which will be tested in the near future.

[1]  R Mohan,et al.  The biological basis for conformal three-dimensional radiation therapy. , 1991, International journal of radiation oncology, biology, physics.

[2]  James M. Galvin,et al.  Initiation of multileaf collimator conformal radiation therapy , 1993 .

[3]  R. Lindberg,et al.  Conservative surgery and postoperative radiotherapy in 300 adults with soft‐tissue sarcomas , 1981, Cancer.

[4]  P. Schiff,et al.  Promotion of microtubule assembly in vitro by taxol , 1979, Nature.

[5]  G. Iliakis,et al.  Level of DNA double-strand break rejoining in Chinese hamster xrs-5 cells is dose-dependent: implications for the mechanism of radiosensitivity. , 1992, International journal of radiation biology.

[6]  J. Tepper,et al.  Postoperative radiation therapy of rectal cancer. , 1987, International journal of radiation oncology, biology, physics.

[7]  C. Coleman Beneficial liaisons: radiobiology meets cellular and molecular biology , 1993 .

[8]  R. Neta,et al.  Radioprotection with cytokines--learning from nature to cope with radiation damage. , 1991, Cancer cells.

[9]  L. Leksell The stereotaxic method and radiosurgery of the brain. , 1951, Acta chirurgica Scandinavica.

[10]  L D Lunsford,et al.  Stereotactic radiosurgery for arteriovenous malformations of the brain. , 1991, Journal of neurosurgery.

[11]  T LoSasso,et al.  The use of a multi-leaf collimator for conformal radiotherapy of carcinomas of the prostate and nasopharynx. , 1993, International journal of radiation oncology, biology, physics.

[12]  I. Kaplan,et al.  Stereotaxic radiosurgery for brain metastases: the importance of adjuvant whole brain irradiation. , 1992, International journal of radiation oncology, biology, physics.

[13]  D. Rosenthal,et al.  Treatment of the patient with stage M0 soft tissue sarcoma. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  L. Hartwell,et al.  The RAD9 gene controls the cell cycle response to DNA damage in Saccharomyces cerevisiae. , 1988, Science.

[15]  R. Schilsky Biochemical pharmacology of chemotherapeutic drugs used as radiation enhancers. , 1992, Seminars in oncology.

[16]  W. K. Sinclair SENSITIVITY TO MITOTIC DELAY AND STAGE IN THE CYCLE. , 1972 .

[17]  P. Warde,et al.  Does thoracic irradiation improve survival and local control in limited-stage small-cell carcinoma of the lung? A meta-analysis. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  B. Vogelstein,et al.  A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia , 1992, Cell.

[19]  E. Hall,et al.  Taxol sensitizes human astrocytoma cells to radiation. , 1992, Cancer research.

[20]  R. Muschel,et al.  Cyclin B expression in HeLa cells during the G2 block induced by ionizing radiation. , 1991, Cancer research.

[21]  M. Wick,et al.  In vivo radioprotective effects of recombinant human granulocyte colony-stimulating factor in lethally irradiated mice. , 1990, Blood.

[22]  M. Mohiuddin,et al.  High-dose preoperative radiation and radical sphincter-preserving surgery for rectal cancer. , 1991, Archives of surgery.

[23]  M Baum,et al.  Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  J. Cooper,et al.  Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. , 1992, The New England journal of medicine.

[25]  H. Scher Chemotherapy for invasive bladder cancer: neoadjuvant versus adjuvant. , 1990, Seminars in oncology.

[26]  G. Iliakis Radiation-induced potentially lethal damage: DNA lesions susceptible to fixation. , 1988, International journal of radiation biology and related studies in physics, chemistry, and medicine.

[27]  W. Hong,et al.  Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. , 1991, The New England journal of medicine.

[28]  W. Meyers,et al.  Effective surgical adjuvant therapy for high-risk rectal carcinoma. , 1991, The New England journal of medicine.

[29]  J Cuzick,et al.  Overview of randomized trials comparing radical mastectomy without radiotherapy against simple mastectomy with radiotherapy in breast cancer. , 1987, Cancer treatment reports.

[30]  D. Hallahan,et al.  Gene therapy targeted by ionizing radiation. , 1992, International journal of radiation oncology, biology, physics.

[31]  J. Maybaum,et al.  Fluoropyrimidines as Radiation Sensitizers. , 1993, Seminars in radiation oncology.

[32]  E. Glatstein,et al.  Primary treatment of large and massive adult sarcomas with iododeoxyuridine and aggressive hyperfractionated irradiation , 1991, Cancer.

[33]  W. Shipley,et al.  Selective bladder preservation by combination treatment of invasive bladder cancer. , 1993, The New England journal of medicine.

[34]  H D Suit,et al.  Local control and patient survival. , 1992, International journal of radiation oncology, biology, physics.

[35]  R. Gray,et al.  Identification of a subgroup of patients with breast cancer and histologically positive axillary nodes receiving adjuvant chemotherapy who may benefit from postoperative radiotherapy. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[36]  Marc L. Kessler,et al.  The use of 3-D dose volume analysis to predict radiation hepatitis. , 1991 .

[37]  R. Okayasu,et al.  Variation through the cell cycle in the dose-response of DNA neutral filter elution in X-irradiated synchronous CHO-cells. , 1988, International journal of radiation biology and related studies in physics, chemistry, and medicine.

[38]  J. Tepper,et al.  The treatment of soft-tissue sarcomas of the extremities: prospective randomized evaluations of (1) limb-sparing surgery plus radiation therapy compared with amputation and (2) the role of adjuvant chemotherapy. , 1982, Annals of surgery.

[39]  C. Catton,et al.  Epidermoid anal cancer: treatment by radiation alone or by radiation and 5-fluorouracil with and without mitomycin C. , 1991, International journal of radiation oncology, biology, physics.

[40]  P. Fitzpatrick,et al.  Half body radiotherapy , 1976 .

[41]  J. Crook,et al.  Results of a randomized phase-III trial to evaluate the efficacy of strontium-89 adjuvant to local field external beam irradiation in the management of endocrine resistant metastatic prostate cancer. , 1993, International journal of radiation oncology, biology, physics.

[42]  P. Rubin,et al.  ASTRO plenary: interfraction interval is a major determinant of late effects, with hyperfractionated radiation therapy of carcinomas of upper respiratory and digestive tracts: results from Radiation Therapy Oncology Group protocol 8313. , 1991, International journal of radiation oncology, biology, physics.

[43]  C. Wong,et al.  Local excision and post-operative radiation therapy for rectal carcinoma. , 1993, International journal of radiation oncology, biology, physics.

[44]  M. Martel,et al.  Results of high-dose thoracic irradiation incorporating beam's eye view display in non-small cell lung cancer: a retrospective multivariate analysis. , 1993, International journal of radiation oncology, biology, physics.

[45]  R Mohan,et al.  A model for computer-controlled delivery of 3-D conformal treatments. , 1992, Medical physics.

[46]  C B Begg,et al.  The effect of local control on metastatic dissemination in carcinoma of the prostate: long-term results in patients treated with 125I implantation. , 1991, International journal of radiation oncology, biology, physics.

[47]  M. Hauer-Jensen,et al.  Chemotherapy and radiation therapy for anal carcinoma. Survival and late morbidity , 1991, Cancer.

[48]  L J Peters,et al.  Accelerated fractionation in the radiation treatment of head and neck cancer. A critical comparison of different strategies. , 1988, Acta oncologica.

[49]  J. Denham The radiation dose-response relationship for control of primary breast cancer. , 1986, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[50]  A. Fornace Mammalian genes induced by radiation; activation of genes associated with growth control. , 1992, Annual review of genetics.

[51]  S. Lippman,et al.  Head and Neck Cancer , 1993, Cancer treatment and research.

[52]  D. Hallahan,et al.  Biological consequences of gene regulation after ionizing radiation exposure. , 1991, Journal of the National Cancer Institute.

[53]  K. Winston,et al.  Linear accelerator as a neurosurgical tool for stereotactic radiosurgery. , 1988, Neurosurgery.

[54]  R Mohan,et al.  A comprehensive three-dimensional radiation treatment planning system. , 1988, International journal of radiation oncology, biology, physics.

[55]  P. Jeggo,et al.  Studies on mammalian mutants defective in rejoining double-strand breaks in DNA. , 1990, Mutation research.

[56]  L. Delclos,et al.  Radiotherapy for anal cancer: experience from 1979-1987. , 1989, International journal of radiation oncology, biology, physics.

[57]  S Schraub,et al.  Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC cooperative group of radiotherapy. , 1992, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[58]  J. Ware,et al.  Chemotherapy with or without radiation therapy in limited small-cell carcinoma of the lung. , 1987, The New England journal of medicine.

[59]  J. Bedford,et al.  On the nature of a defect in cells from individuals with ataxia-telangiectasia. , 1985, Science.

[60]  H. Sandler,et al.  Dose escalation for stage C (T3) prostate cancer: minimal rectal toxicity observed using conformal therapy. , 1992, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[61]  V. Vaitkevicius,et al.  Combined therapy for cancer of the anal canal: A preliminary report , 1974, Diseases of the colon and rectum.

[62]  C. Song,et al.  Effects of recombinant growth factors on radiation survival of human bone marrow progenitor cells. , 1989, International journal of radiation oncology, biology, physics.

[63]  C. C. Wang Radiation Therapy for Head and Neck Neoplasms: Indications, Techniques, and Results , 1983 .

[64]  M. M. ELKIND,et al.  X-Ray Damage and Recovery in Mammalian Cells in Culture , 1959, Nature.

[65]  N. Bleehen,et al.  A Medical Research Council trial of two radiotherapy doses in the treatment of grades 3 and 4 astrocytoma. The Medical Research Council Brain Tumour Working Party. , 1991, British Journal of Cancer.

[66]  K. Ang,et al.  Is the rate of repair of radiation-induced sublethal damage in rat spinal cord dependent on the size of dose per fraction? , 1987, International journal of radiation oncology, biology, physics.

[67]  K. Zedeler,et al.  Evaluation of radiotherapy in high-risk breast cancer patients: report from the Danish Breast Cancer Cooperative Group (DBCG 82) Trial. , 1990, International journal of radiation oncology, biology, physics.

[68]  G. Rosner,et al.  Post-mastectomy radiotherapy following adjuvant chemotherapy and autologous bone marrow transplantation for breast cancer patients with ≥ 10 positive axillary lymph nodes , 1992 .

[69]  M. Kessler,et al.  Treatment of primary hepatobiliary cancers with conformal radiation therapy and regional chemotherapy. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[70]  R. Slebos,et al.  Loss of a p53-associated G1 checkpoint does not decrease cell survival following DNA damage. , 1993, Cancer research.

[71]  Federico Colombo,et al.  Linear accelerator radiosurgery of cerebral arteriovenous malformations. , 1989 .

[72]  J. M. Taylor,et al.  The hazard of accelerated tumor clonogen repopulation during radiotherapy. , 1988, Acta oncologica.

[73]  D. Allan Radiation-induced apoptosis: its role in a MADCaT (mitosis-apoptosis-differentiation-calcium toxicity) scheme of cytotoxicity mechanisms. , 1992, International journal of radiation biology.

[74]  S A Leibel,et al.  The effect of local-regional control on distant metastatic dissemination in carcinoma of the head and neck: results of an analysis from the RTOG head and neck database. , 1991, International journal of radiation oncology, biology, physics.

[75]  Scott W. Lowe,et al.  p53 is required for radiation-induced apoptosis in mouse thymocytes , 1993, Nature.

[76]  A S Lichter,et al.  Mastectomy versus breast-conserving therapy in the treatment of stage I and II carcinoma of the breast: a randomized trial at the National Cancer Institute. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[77]  F. Uckun,et al.  Role of tyrosine phosphorylation in radiation-induced activation of c-jun protooncogene in human lymphohematopoietic precursor cells. , 1993, Cancer research.

[78]  S. T. Cantril,et al.  Efficacy of radiation therapy alone for limited squamous cell carcinoma of the anal canal. , 1988, International journal of radiation oncology, biology, physics.

[79]  W. Powlis,et al.  Hyperfractionated radiation therapy and bis-chlorethyl nitrosourea in the treatment of malignant glioma--possible advantage observed at 72.0 Gy in 1.2 Gy B.I.D. fractions: report of the Radiation Therapy Oncology Group Protocol 8302. , 1993, International journal of radiation oncology, biology, physics.

[80]  K. Kohn,et al.  Role of the p53 tumor suppressor gene in cell cycle arrest and radiosensitivity of Burkitt's lymphoma cell lines. , 1993, Cancer research.

[81]  A. Lindblad,et al.  Adjuvant postoperative radiotherapy and chemotherapy in rectal carcinoma: a review of the Gastrointestinal Tumor Study Group experience. , 1988, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[82]  Sandler,et al.  Clinical Experience With Three-Dimensional Treatment Planning. , 1992, Seminars in Radiation Oncology.

[83]  A. Haimovitz-Friedman,et al.  Radiation Damage in Endothelial Cells Autocrine Effects of Fibroblast Growth Factor in Repair of Updated , 2006 .

[84]  J. Overgaard,et al.  Postoperative radiotherapy in Dukes' B and C carcinoma of the rectum and rectosigmoid: A randomized multicenter study , 1986, Cancer.

[85]  J. Papillon,et al.  Interstitial curietherapy in the conservative treatment of anal and rectal cancers. , 1989, International journal of radiation oncology, biology, physics.

[86]  T. R. Munro The site of the target region for radiation-induced mitotic delay in cultured mammalian cells. , 1970, Radiation research.

[87]  L. Einhorn,et al.  Small cell carcinoma of the lung. , 1986, Critical reviews in oncology/hematology.

[88]  J P Pignon,et al.  A meta-analysis of thoracic radiotherapy for small-cell lung cancer. , 1992, The New England journal of medicine.

[89]  G E Hanks,et al.  Recent patterns of growth in radiation therapy facilities in the United States: a patterns of care study report. , 1992, International journal of radiation oncology, biology, physics.

[90]  M. Prados,et al.  Evaluation of bromodeoxyuridine in glioblastoma multiforme: a Northern California Cancer Center Phase II study. , 1991, International journal of radiation oncology, biology, physics.

[91]  J Rosenman,et al.  Recent advances in radiotherapy treatment planning. , 1991, Cancer investigation.

[92]  A. Lichter Is radiation therapy in conjunction with mastectomy indicated for the treatment of operable breast cancer? , 1987, Cancer investigation.

[93]  M. Elkind DNA damage and cell killing cause and effect? , 1985, Cancer.

[94]  R. Makuch,et al.  Chemotherapy alone or chemotherapy with chest radiation therapy in limited stage small cell lung cancer. A prospective, randomized trial. , 1987, Annals of internal medicine.

[95]  S. Steinberg,et al.  Randomized clinical trial of preoperative and postoperative adjuvant chemotherapy with cisplatin, vindesine, and bleomycin for carcinoma of the esophagus. , 1988, The Journal of thoracic and cardiovascular surgery.

[96]  Dose response of squamous cell carcinomas of the upper respiratory and digestive tracts. , 1980, The British journal of cancer. Supplement.

[97]  A S Lichter,et al.  Three-dimensional conformal radiation therapy: a testable hypothesis. , 1991, International journal of radiation oncology, biology, physics.

[98]  T E Schultheiss,et al.  Can modest escalations of dose be detected as increased tumor control? , 1992, International journal of radiation oncology, biology, physics.

[99]  H. Rockette,et al.  Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: results from NSABP protocol R-01. , 1988, Journal of the National Cancer Institute.

[100]  W. Dewey,et al.  Radiation-induced cycle delay in synchronized Chinese hamster cells: comparison between DNA synthesis and division. , 1973, Radiation research.

[101]  W. Enneking,et al.  The effect of the anatomic setting on the results of surgical procedures for soft parts sarcoma of the thigh , 1981, Cancer.

[102]  T. Lawrence,et al.  The effect of single versus double-strand substitution on halogenated pyrimidine-induced radiosensitization and DNA strand breakage in human tumor cells. , 1990, Radiation research.

[103]  C. Redmond,et al.  Fraud in breast-cancer trials. , 1994, The New England journal of medicine.

[104]  R. Weichselbaum,et al.  Concomitant chemoradiotherapy: rationale and clinical experience in patients with solid tumors. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.